Aspect Biosystems has developed a patent-pending 3D bioprinting platform and human cellculture technology, capable of creating living human tissues on demand. Aspect Biosystems’ initial products and services aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing pharmaceutical companies, contract research organizations, and researchers with physiologically-relevant 3D human tissue models that they can employ in the development of new drugs and therapies.
Industry - Alumni
